Mechanism of Antiviral Flashcards
- Which pathogens are we fighting against when we use :
- Antibiotics
- Antivirals
Antibiotics = fighting against bacteria
Anti-virals = fighting against viruses
- Why is it important we have anti-virals?
- Prevent epidemics ( eg influenza,ebola)
- Some viruses lead to cancer (eg Hep B/C and human papilloma virus)
- To treat acute inflammatory infections (herpes)
- What are some (3) acute infections we can treat using aciclovir?
- Influenza
- Chickenpox
- Herpes
- There are numerous agents we can use to treat chronic infections. List three examples of viral chronic infections?
- HCV
- HBV
- HIV
- What is the difference between pre-exposure prophylaxis and post-exposure prophylaxis ?
Pre-exposure prophylaxis = given to PREVENT infection eg if there’s a high chance someone will be exposed to HIV they would be given a HIV PrEP
Post-exposure prophylaxis = after someone has been exposed to an infection, important its given within 72 hours (preferably 24hrs) eg HIV PEP
- What type of antiviral could you use for a reactivated infection?
You can use a prophylaxis
- Give some examples of when you would have a reactivated infection and give examples of the specific drugs you could use to treat these?
Transplation/Immunosuppression/Cancer are some examples of why you may get re-infected.
For eg reactivated infection of CMV (shingles in adults) would be treated by Ganciclovir or Foscarnet
- What is the principle of selective toxicity that we want antivirals to achieve ?
We want anti-virals to achieve this idea of selective toxicity - harm the microorganisms NOT the host.
- What makes it possible for selective toxicity
Possible if :
- Target of the anti viral is inside the microbe, not the host
- There are differences and structure and metabolic pathways between host and the pathogen
- Why is it so difficult to develop effective, non-toxic anti-viral drugs ?
Give 7 reasons
Viruses enter cells using cellular receptors which may have other functions
Viruses must replicate inside cells – obligate intracellular parasites
Viruses take over the host cell replicative machinery
Virsues have high mutation rate - quasispecies
Anti-virals must be selective in their toxicity
i.e. exert their action only on infected cells
Some viruses are able to remain in a latent state e.g. herpes, HPV
Some viruses are able to integrate their genetic material into host cells e.g. HIV
- Briefly summarise the virus life cycle?
- Virus recognises the cell and attaches to the membrane and gets internalised by either :
- Endocytosis
- Membrane Fusion - Once the virus is inside, it uncoats and releases its genome
- Genome replicates itself using cells machinery
- Virus makes mRNA–> goes to ribosome —> viral protein
- Viral reassembles itself by either :
- Budding through the membrane
- Cell Lysis
- What are some considerations when making an antiviral that is specifically targeting different stages of infection
Cellular receptor may have other important function
Viral enzymes may be very similar to host
Blocking cellular enzyme may kill cell
- What are some different modes of actions of antivirals?
Preventing virus adsorption onto host cell
Preventing penetration
Preventing viral nucleic acid replication (nucleoside analogues)
Preventing maturation of virus
Preventing virus release
- What is Amantadine ?
- Which virus do we use it for
- How does it work
Amantadine’s mode of action is preventing uncoating. Does this by blocking low pH endosome dependant on coating M2 Protein
Effective for Influenza A
- What do :
-Acyclovir
-Ganciclovir
-Ribavarin
use as a mode of method?
They inhibit nucleic acid polymerisation –> target reverse transciptases or DNA polymerases
- How does Ribavarin specifically work?
Its an analogue of Guanosine , it compromises genome replication
- How cam we use protease inhibitors to target HIV?
As we cant make viral proteins , it blocks particle maturation and assembly of the virus
- What is Zanamivir?
what is its mode of action
which virus does it target
Blocks release of virus from the cell
Targets influenza
- One main mode of action of antivirals is targeting virally encoded enzymes that sufficiently different from human counterparts, what are some examples of this?
Thymidine kinase and HSV/VZV/CMV Protease of HIV Reverse transcriptase of HIV DNA polymerases Neuraminidase of influenza virus-> stops virus from budding
- What virus causes muco-cutaneous lesions ?
Herpes Simplex
- Which virus causes chickenpox and Shingles (in adult)
Varicella Zoster Virus
- There are 8 types of Herpes, list any 4 of those 8?
Herpes simplex type I (HSV-1). Herpes simplex type II (HSV-2). Varicella-zoster virus (VZV/HHV-3). Epstein-Barr virus (EBV/HHV-4). Cytomegalovirus (CMV/HHV-5). Herpes virus type 6 (HBLV/HHV-6). Herpes virus type 7 (HHV-7). Kaposi's sarcoma herpes virus (KSHV/HHV-8).
- Which type of Herpes is aciclovir good at treating and which herpes can we use aciclovir as a prophylaxis for?
We can use it for HSV and VZV treatment
We can it as a prophylaxis for CMV and EBV
- Seeing as we cant use aciclovir for treatment of CMV , which three drugs can we use as treatment of CMV?
- > Ganciclovir
- > Foscarnet
- > Cidofovir
- Explain the mechanism of aciclovir?
Aciclovir is an analogue of GTP ( missing a 3’OH group so that when incorporated into DNA it acts as chain terminator )
- Aciclovir activated by phosphorylation by viral thymidine kinase (this is encoded by the genome of the virus)
- Aciclovir is now stable but gets di- and tri- phosphorylated by Cellular GDP kinases
- Now its in the active drug form- a competitive inhibitor
- Competes with GTP for Viral DNA polymerase
- Once incorporated , acts as chain terminator and stops viral genome binding to Viral DNA polymerase
- In which 2 ways does Aciclovir achieve low toxicity to the host?
- Selectively activated in cells that are infected- mainly activated by viral thymidine kinase but only infected cells have thymidine kinase. Unlikely for drug to be activated in uninfected cells
- Once phosphorylated by cellular kinase – product which has selective toxicity to the viral DNA polymerase is 30x more active against viral polymerases than host polymerases.